StockTipsArenaBeta

BUY Alkem Laboratories Limited — ICICI Securities

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)13 Aug 2025via Institutional / Brokerage Research

Entry₹5,388.5Inferred
Target₹6,065
Total upside +12.55% (call closed)
Stop lossNot given
At expiry₹5,449.513 Aug 2026, 3:30 pm
Expired+1.13%auction close
Follow ICICI Securities for new calls(67% target hit, 1025 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 8 active Long-term calls on ALKEMSee 161 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026
11 supporting3 neutral2 opposing
Supports the BUY call (11)

Four midcap stocks near 52-week highs that still look cheap

NewsLivemint·11 Aug · 2d ago

(opens in new tab)

Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

NewsLivemint·20 Jul · 3w ago

(opens in new tab)

Alkem Laboratories Share Price: મોટી આંતરરાષ્ટ્રીય ડીલ પૂર્ણ! સ્વિસ કંપની Occlutech Holding AG માં મેજર હિસ્સો હસ્તગત

NewsGoogle News·17 Jul · 4w ago

(opens in new tab)

Alkem Laboratories: சுவிஸ் நிறுவனத்தில் பங்குதாரர் ஆனார்! மருத்துவ சாதன உலகில் புதிய அத்தியாயம்

NewsGoogle News·17 Jul · 4w ago

(opens in new tab)

Alkem Laboratories: స్విస్ కంపెనీ Occlutech Holding AG కొనుగోలు పూర్తి

NewsGoogle News·17 Jul · 4w ago

(opens in new tab)
Neutral / worth noting (3)

Alkem Laboratories accepts resignation of Dr. Jitendra Singh Huda

NewsGoogle News·25 Jul · 3w ago

(opens in new tab)

Alkem Laboratories Ltd has acquired 79,36,50,794 equity shares at Rs. 13.86 per share from its wholly owned subsidiary, Alkem Medtech Private Limited, on a rights basis. The acquisition aims to secure

BSE · Company Update·16 Jul · 4w ago

(opens in new tab)
Weighs against the BUY call (2)

Alkem Laboratories’ Daman facility gets US FDA OAI classification after seven observations

NewsCnbc-Tv18·6 Aug · 6d ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·29 May · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from ICICI Securities

Every call and its outcome